| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9319363 | European Urology | 2005 | 5 Pages |
Abstract
According to our data, there is a significant correlation between loss of p16 expression and tumor progression in patients with minimally-invasive bladder cancer. Immunohistochemical p16 staining may therefore represent a useful tool of providing additional information on the clinical outcome of these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Stefan Krüger, Anne Mahnken, Ingo Kausch, Alfred C. Feller,